NCT00835393View on ClinicalTrials.gov

Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

Pantoprazole Sodium 40 mg delayed-release tablets

1 x 40 mg

DRUG

PROTONIX® 40 mg delayed-release tablets.

1 x 40 mg

Trial Locations (2)

63301

Gateway Medical Research, Inc., Saint Charles

77099

Bioassay Laboratory, Inc., Houston

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835393 - Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter